Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cellulose-derived viscosity modifier (substance) |
Is a |
True |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
viskoelastisk øjenmiddel |
Is a |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
Carbomer (substance) |
Is a |
True |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
Viscosity modifier adverse reaction |
Causative agent |
True |
Viscosity modifier (substance) |
Inferred relationship |
Some |
1 |
allergi over for viskositetsmodifikator |
Causative agent |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
Product containing polyvinyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
polyvinylalkohol 1,4 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
Product containing precisely polyvinyl alcohol 14 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
Polyvinyl alcohol 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
povidon 5 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
viskositetsmodifikator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
breve og granulat til størkning af sekretion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
Product containing povidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
middel til størkning af sekretion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
tablet til størkning af sekretion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
naphazolinhydrochlorid + polyvinylalkohol + zinksulfat 0,02 % wt/vol/0,25 % wt/vol/0,25 % wt/vol dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
strip til størkning af sekretion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
xanthangummi |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
Product containing Acacia (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
Product containing Acacia and starch and tragacanth (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
|
allergi over for viskositetsmodifikator |
Causative agent |
False |
Viscosity modifier (substance) |
Inferred relationship |
Some |
1 |